Among 6,609 participants, 46% had diabetes (96.4% with type 2 diabetes mellitus), and approximately 31% had DKD [48]
Any tips for fellow readers
9 58% of patients stop taking GLP-1s before seeing a clinically meaningful health benefit 10 We have to be cautious with GLP-1s, as were still learning where they are most effective and what the long-term side effects are, explains Dr
In short, the easier your app makes it to stay consistent, the better your odds of success
Stable isotope dilution LC-MS/MS was used to quantify d 9 -TMAO ( A ), d 9 -BB ( B ), and d 9 -l-carnitine ( C ) in plasma collected from sequential venous blood draws at the noted times
Most protocols recommend daily use for 48 weeks, followed by a short break to allow your body to reset before starting another cycle